OpenLegislation

Division 2 PRODUCT FAMILY COMPOSITION AND FORMULATIONF1

United Kingdom

Original text. Later amendments are not shown.

  1. 2.1Qualitative and quantitative information on the composition of the family
  2. 2.2Type(s) of formulation

Annotations

Textual amendments

F1

Substituted by Commission Implementing Regulation (EU) 2020/1995 of 4 December 2020 amending Implementing Regulation (EU) No 2018/1261 as regards administrative changes of the information related to the Union authorisation of the biocidal product family ‘Hypred’s iodine based products’ (Text with EEA relevance).